One model induces both mutant p53 and MDM2 haploinsufficiency during early development, highlighting MDM2's critical role in hematopoiesis, while the second model mimics CH by introducing mutant p53 in adult hematopoietic stem cells (HSCs). This evidence concerns the gene TP53 and cyclic hematopoiesis.